A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Clinical trial NCT03671044 · RECRUITING
Trial details
- NCT number
- NCT03671044
- Sponsor
- Jina Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2025-05-31
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.